Call Us: 888-488-2702

Supreme Court slates generic drug ‘pay-for-delay’ case

By on Dec 8, 2012 in News |

The U.S. Supreme Court has agreed to hear arguments in a “pay-for-delay” case that has the Federal Trade Commission accusing generic drugmakers of violating competition laws by agreeing to accept $42 million in annual payments in exchange for not…